<DOC>
	<DOCNO>NCT00133172</DOCNO>
	<brief_summary>The purpose study compare safety efficacy tacrolimus-based 5-day steroid rapid withdrawal immunoprophylactic regimen de novo renal transplantation .</brief_summary>
	<brief_title>Effect Rapid Steroid Withdrawal Subclinical Markers Rejection</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Subject legally acceptable guardian sign date Research Ethics Board ( REB ) approve informed consent form willing able follow study procedure . Subject recipient first second cadaveric living donor mismatch ( least one mismatch ) renal transplant . Subject 18 year age time transplant . If female childbearing potential , subject negative pregnancy test utilizes adequate contraceptive method Recipients kidney donor 60 year age old Recipients donation cardiac death ( DCD ) donor Recipients combine transplant ( e.g . kidneypancreas , lung , heart ) Subjects second renal allograft original graft &lt; 2 year , unless initial graft lose early ( 1 year less ) post transplant course due technical surgical failure Subjects current/latest pretransplant panel reactive antibody ( PRA ) &gt; 20 Subjects hepatitis B &amp; C , HIV cancer ( exclude successfully excise squamous basal cell carcinoma ) Subjects receive allograft cold ischemia time 24 hour great Subjects receive investigational drug within three month prior randomization Subjects breastfeeding Subjects know hypersensitivity tacrolimus , mycophenolate mofetil , methylprednisolone , basiliximab , prednisone , relate drug excipients Subjects significant disease ( e.g . uncontrolled infection ) disability ( e.g . cognitive deficit ) prevent understanding adherence protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Anti-rejection therapy</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Antirejection</keyword>
	<keyword>Renal Transplantation</keyword>
	<keyword>Transplantation , Renal</keyword>
	<keyword>Transplantation , Kidney</keyword>
	<keyword>Grafting , Kidney</keyword>
</DOC>